Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic
Author(s) -
Kaveh Rezaei Bookani,
Iva Minga,
Manisha Chander,
Ksenia Hankewych,
Matthew Plassmeier,
Alfonso Tafur
Publication year - 2020
Publication title -
clinical and applied thrombosis/hemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 53
eISSN - 1938-2723
pISSN - 1076-0296
DOI - 10.1177/1076029620947476
Subject(s) - pandemic , medicine , isolation (microbiology) , covid-19 , atrial fibrillation , intensive care medicine , medical emergency , social distance , health care , disease , infectious disease (medical specialty) , biology , economic growth , microbiology and biotechnology , economics
The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at anticoagulation clinics for management of their anticoagulation therapy. The need for isolation during COVID-19 pandemic can potentially limit access to health care including anticoagulation clinics and directly affect the care of patients on chronic anticoagulation. Therefore, we created a drive-through clinic to bridge the gap of continuation of care and preservation of social distancing precautions. In this manuscript, we report the steps in implementing such initiative which can be applied to other clinics during a pandemic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom